Troy Cox, Director at MapLight Therapeutics, Inc., holds 23.48K shares in MapLight Therapeutics, Inc. (Ticker: MPLT), holds 475.70K shares in Standard BioTools (Ticker: LAB), holds 328.74K shares in SOPHiA GENETICS (Ticker: SOPH). Most recently, Troy Cox Bought ― shares of MapLight Therapeutics, Inc. on Jul 28, 2026 for an estimated value of $148.70K.
Troy Cox latest transaction was an Informative Buy of $148.70K.
What was Troy Cox's most profitable transaction?
Troy Cox’s most profitable transaction was an Informative Buy of MPLT stock on July 28, 2026. The return on the trade was -4.50%.
What is Troy Cox's role in MapLight Therapeutics, Inc.?
Troy Cox's role in MapLight Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.